A tribute to two driving forces in hepatology: Profs Gerok and Groszmann
In memoriam: Prof. Wolfgang Gerok (1926–2021) and Prof. Roberto Groszmann (1939–2021) 20 January 2021 EASL is greatly saddened to hear of the passing earlier this week of two giants of hepatology, Prof.…
Significant improvements in mechanistic biomarkers of how Dialive™ improves organ function
About EASL and the ALIVER Consortium The ALIVER Consortium of 11 institutions from seven European countries developed an innovative liver dialysis machine called Dialive™. This device helps the liver to regenerate naturally…
Looking towards bright horizons for 2021
This year has been unlike any other. COVID-19 brought unimaginable challenges to the medical community, placing you at the forefront of the pandemic. The year 2020 posed unique questions to those of…
Study identifies causes precipitating the most serious stage of cirrhosis
Researchers from EF Clif identify the causes that precipitate the onset of the most serious stage of cirrhosis: the syndrome of Acute-On-Chronic Liver Failure (ACLF). Barcelona, December 9, 2020 – A new investigation…
EASL engages in Awareness Week on Alcohol-Related Harm 2020
16 November 2020 Awareness Week on Alcohol-Related Harm (AWARH) takes place yearly. It serves to raise awareness among EU policymakers of the types of harm caused by alcohol, to increase awareness about…
Announcing the winners of our #EASLshare competition
As a fully digital three-day event, Digital ILC 2020 brought together thousands of delegates from all over the world. EASL invited you, the delegates, to take part in the first ever EASL…
Patients, science, and policy forging positive change for public health
On 4 November 2020, EASL held its first online Patient Forum, a vibrant exchange exploring synergies between our association of professionals and regional patient organisations engaged in the fight against liver disease.…